Conduit Pharmaceuticals Inc. has filed a Form 8-K with the SEC, disclosing non-compliance with Nasdaq's continued listing requirements. Specifically, the company's market value of publicly held shares and market value of listed securities fell below the minimum thresholds. Conduit has 180 days to regain compliance. Additionally, undisclosed dispositions of substantial company shares by a director and a significant stockholder's shares being under third-party pledge were discovered. The board has formed a Special Committee and a Trading Review Committee to investigate and address these issues.

Conduit Pharmaceuticals Inc. has filed a Form 8-K with the SEC, disclosing non-compliance with Nasdaq's continued listing requirements. Specifically, the company's market value of publicly held shares and market value of listed securities fell below the minimum thresholds. Conduit has 180 days to regain compliance. Additionally, undisclosed dispositions of substantial company shares by a director and a significant stockholder's shares being under third-party pledge were discovered. The board has formed a Special Committee and a Trading Review Committee to investigate and address these issues.